Elena López‐Ruiz

ORCID: 0000-0002-7863-0497
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Electrospun Nanofibers in Biomedical Applications
  • 3D Printing in Biomedical Research
  • Osteoarthritis Treatment and Mechanisms
  • Mesenchymal stem cell research
  • Bone Tissue Engineering Materials
  • Tissue Engineering and Regenerative Medicine
  • Cancer Cells and Metastasis
  • Collagen: Extraction and Characterization
  • Wound Healing and Treatments
  • Additive Manufacturing and 3D Printing Technologies
  • Periodontal Regeneration and Treatments
  • Angiogenesis and VEGF in Cancer
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Lower Extremity Biomechanics and Pathologies
  • RNA Interference and Gene Delivery
  • Cancer Research and Treatments
  • Graphene and Nanomaterials Applications
  • Knee injuries and reconstruction techniques
  • Retinal Diseases and Treatments
  • Extracellular vesicles in disease
  • Bone and Dental Protein Studies
  • Pancreatic and Hepatic Oncology Research
  • Microplastics and Plastic Pollution
  • Pancreatic function and diabetes
  • Hydrogels: synthesis, properties, applications

Universidad de Jaén
2014-2025

Universidad de Granada
2015-2025

Instituto de Investigación Biosanitaria de Granada
2018-2025

Andalusian Health Service
2021

Aarhus University
2017

Instituto de Investigación Biomédica de A Coruña
2009-2013

Complexo Hospitalario Universitario A Coruña
2009-2013

Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine
2013

Hospital San Juan de la Cruz
2004

The use of decellularized extracellular matrix (dECM) as a biomaterial has been an important step forward for the development functional tissue constructs. In addition to tissues and organs, cell cultures are gaining lot attention alternative source dECM. this work, novel biomimetic hydrogel is developed based on dECM obtained from mesenchymal stem cells (mdECM) cartilage engineering. To end, seeded under specific culture conditions generate early chondrogenic (ECM) providing cues elements...

10.1002/adhm.202001847 article EN cc-by-nc-nd Advanced Healthcare Materials 2021-03-01

Biofabrication technologies with layer-by-layer simultaneous deposition of a polymeric matrix and cell-laden bioinks (also known as bioprinting) offer an alternative to conventional treatments regenerate cartilage tissue. Thermoplastic polymers, like poly-lactic acid, are easy print using fused modeling, the shape, mesh structure, biodegradation time, stiffness can be easily controlled. Besides some them being clinically approved, high manufacturing temperatures used in bioprinting...

10.1177/1535370218821128 article EN Experimental Biology and Medicine 2019-01-01

In breast cancer (BC), the presence of stem cells (CSCs) has been related to relapse, metastasis, and radioresistance. Radiotherapy (RT) is an extended BC treatment, but not always effective. CSCs have several mechanisms radioresistance in place, some miRNAs are involved cellular response ionizing radiation (IR). Here, we studied how IR affects expression stemness different molecular subtypes. Exposition doses 2, 4, or 6 Gy affected their phenotype, functional characteristics, pluripotency...

10.1002/1878-0261.12635 article EN cc-by Molecular Oncology 2020-01-13

Abstract Conventional in vitro cancer models do not accurately reproduce the tumor microenvironment (TME), so three-dimensional (3D)-bioprinting represents an excellent tool to overcome their limitations. Here, two multicellular tri-layered malignant melanoma (MM) composed by stem cells (CSCs) isolated from a MM established cell line or primary-patient derived line, fibroblasts, mesenchymal cells, and endothelial embedded within agarose-collagen type I hydrogel were bioprinted....

10.1088/1758-5090/ac8dc6 article EN cc-by Biofabrication 2022-08-30

Geographic atrophy (GA) secondary to age-related macular degeneration is a common cause of blindness worldwide. Given the recent approval first therapy for GA, pegcetacoplan, we critically appraise methodological aspects phase 3 clinical trials published so far in this disease relation their design, analysis and interpretation. We reviewed some key attributes all GA available main public registry as 20 May 2023. The topics discussed included types endpoints, eligibility criteria, p-value...

10.3390/biomedicines11061548 article EN cc-by Biomedicines 2023-05-26
Coming Soon ...